Apellis Pharmaceuticals, Inc.

DB:1JK Stock Report

Market Cap: €4.8b

Apellis Pharmaceuticals Management

Management criteria checks 2/4

Apellis Pharmaceuticals' CEO is Cedric Francois, appointed in Sep 2009, has a tenure of 14.75 years. total yearly compensation is $10.37M, comprised of 7.1% salary and 92.9% bonuses, including company stock and options. directly owns 1.51% of the company’s shares, worth €72.94M. The average tenure of the management team and the board of directors is 5.3 years and 8.9 years respectively.

Key information

Cedric Francois

Chief executive officer

US$10.4m

Total compensation

CEO salary percentage7.1%
CEO tenure14.8yrs
CEO ownership1.5%
Management average tenure5.3yrs
Board average tenure8.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Cedric Francois's remuneration changed compared to Apellis Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$417m

Dec 31 2023US$10mUS$735k

-US$529m

Sep 30 2023n/an/a

-US$606m

Jun 30 2023n/an/a

-US$657m

Mar 31 2023n/an/a

-US$691m

Dec 31 2022US$9mUS$681k

-US$652m

Sep 30 2022n/an/a

-US$634m

Jun 30 2022n/an/a

-US$638m

Mar 31 2022n/an/a

-US$702m

Dec 31 2021US$9mUS$647k

-US$746m

Sep 30 2021n/an/a

-US$520m

Jun 30 2021n/an/a

-US$460m

Mar 31 2021n/an/a

-US$360m

Dec 31 2020US$9mUS$619k

-US$345m

Sep 30 2020n/an/a

-US$536m

Jun 30 2020n/an/a

-US$470m

Mar 31 2020n/an/a

-US$423m

Dec 31 2019US$4mUS$560k

-US$305m

Sep 30 2019n/an/a

-US$228m

Jun 30 2019n/an/a

-US$194m

Mar 31 2019n/an/a

-US$156m

Dec 31 2018US$4mUS$550k

-US$128m

Sep 30 2018n/an/a

-US$109m

Jun 30 2018n/an/a

-US$85m

Mar 31 2018n/an/a

-US$64m

Dec 31 2017US$2mUS$400k

-US$51m

Compensation vs Market: Cedric's total compensation ($USD10.37M) is above average for companies of similar size in the German market ($USD3.28M).

Compensation vs Earnings: Cedric's compensation has increased whilst the company is unprofitable.


CEO

Cedric Francois (52 yo)

14.8yrs

Tenure

US$10,373,049

Compensation

Dr. Cedric Francois, M.D., Ph.D. serves as Principal of Vista Therapeutics, Inc. Dr. Francois co-founded Apellis Pharmaceuticals, Inc. in 2009 and has been its Chief Executive Officer, President and Direct...


Leadership Team

NamePositionTenureCompensationOwnership
Cedric Francois
Co-Founder14.8yrsUS$10.37m1.51%
$ 72.9m
Alec Machiels
Co-Founder & Director15.4yrsUS$495.96k0.64%
$ 30.8m
Timothy Sullivan
CFO & Treasurer6.7yrsUS$3.74m0.084%
$ 4.0m
Adam Townsend
Chief Operating Officerless than a yearUS$3.71m0.023%
$ 1.1m
David Watson
General Counsel10.4yrsUS$4.89m0.094%
$ 4.5m
Caroline Baumal
Chief Medical Officer1.4yrsUS$4.43m0.0052%
$ 249.5k
Pascal Deschatelets
Co-Founder & Chief Scientific Officer14.8yrsUS$3.08m0.92%
$ 44.3m
James Chopas
VP, Corporate Controller & Chief Accounting Officer2.8yrsno data0.0085%
$ 410.7k
Meredith Kaya
Senior Vice Presidentno datano datano data
Karen Lewis
Chief People Officer4.1yrsno data0.00073%
$ 35.2k
Peter Hillmen
Head of Hematology Engagement & Member of PNH Scientific Advisory Board2.1yrsno datano data
Victoria Brown
Senior Vice President5.3yrsno data0.0031%
$ 149.6k

5.3yrs

Average Tenure

51.5yo

Average Age

Experienced Management: 1JK's management team is seasoned and experienced (5.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Cedric Francois
Co-Founder14.8yrsUS$10.37m1.51%
$ 72.9m
Alec Machiels
Co-Founder & Director14.8yrsUS$495.96k0.64%
$ 30.8m
Peter Hillmen
Head of Hematology Engagement & Member of PNH Scientific Advisory Board8.9yrsno datano data
Lokchung L. Chan
Independent Chairman of the Board10.9yrsUS$504.08k0.00056%
$ 27.0k
Stephanie O'Brien
Independent Director10.9yrsUS$488.46k0.00056%
$ 27.0k
Gabriel Coscas
Member of AMD Scientific Advisory Board8.9yrsno datano data
Robert Brodsky
Member of PNH Scientific Advisory Board8.9yrsno datano data
Michael Yeadon
Member of Pulmonology Scientific Advisory Board8.9yrsno datano data
Paul Fonteyne
Independent Director4.2yrsUS$489.08k0.0047%
$ 225.9k
A. Dunlop
Independent Director14.3yrsUS$480.96k0.11%
$ 5.2m
Marsha Wills-Karp
Member of Pulmonology Scientific Advisory Boardno datano datano data
Carl Atkinson
Member of Pulmonology Scientific Advisory Board8.9yrsno datano data

8.9yrs

Average Tenure

57.5yo

Average Age

Experienced Board: 1JK's board of directors are considered experienced (8.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.